Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5-Reference-Cited by-同舟云学术

Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5

Published:2015-03-10 Issue:4 Volume:6 Page:439-444
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Carter Percy H.¹,Brown Gregory D.¹,Cherney Robert J.¹,Batt Douglas G.¹,Chen Jing¹,Clark Cheryl M.¹,Cvijic Mary Ellen¹,Duncia John V.¹,Ko Soo S.¹,Mandlekar Sandhya¹,Mo Ruowei¹,Nelson David J.¹,Pang Jian¹,Rose Anne V.¹,Santella Joseph B.¹,Tebben Andrew J.¹,Traeger Sarah C.¹,Xu Songmei¹,Zhao Qihong¹,Barrish Joel C.¹

Affiliation:

1. Departments of Discovery Chemistry, ‡Lead Discovery & Optimization, §Preclinical Candidate Optimization, ∥Molecular Discovery Technologies, and ⊥Disease Sciences & Biology, Research and Development, Bristol-Myers Squibb Company, Princeton, New Jersey 08543, United States

Funder

Bristol-Myers Squibb Company

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml500505q

Reference24 articles.

1. Monocyte and macrophage heterogeneity

2. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments

3. The Many Roles of Chemokines and Chemokine Receptors in Inflammation